Pipelinepharma

20/06/2023

Pipelinepharma is delighted to announce that in May, we have added over 200 additional CTD dossiers from various qualified manufacturers to our marketplace. As a Pipelinepharma Annual Subscription plan holder, you gain exclusive access to the largest database of finished dosage formulations, which includes:

🔹 Access to over 70,000+ products
🔹 Direct negotiation capabilities with manufacturers
🔹 No brokerage fees
🔹 Price of 125 euros per month, billed annually

We are onboarding Business Development and Licensing Managers from pharmaceutical companies who are seeking to expand their pharmaceutical portfolio and streamline their licensing process.

If you are interested in joining our platform and accessing our extensive database of finished dosage formulations, please contact us at support@pipelinepharma.com. We look forward to assisting you in your business development efforts.

01/06/2023

🌟 Pipelinepharma is excited to announce the launch of our Annual Subscription plan, providing access to the largest database of finished dosage formulations! The subscription includes:

🔹 Direct negotiation and collaboration with manufacturers, eliminating the need for any mediation.
🔹 No consultancy or brokerage commission fees.
🔹 Dedicated account manager for personalised support.

For the first 100 clients, the Subscription service is available at the cost of 125 euros per month, billed annually. That's a price lower than that of a single business trip. 🌍✈️💰

We are eager to cooperate with you in finding qualified products for your product pipeline. 🙌💊

▶️ Watch this video to learn more about the benefits of our Annual Subscription plan.



Link to video: https://bit.ly/3N45aKa

The Subscription plan is a paid service that provides exclusive benefits for pharma buyers looking for multiple products on the Pipelinepharma platform.

21/03/2023

Pipelinepharma CEO Mindaugas Zagorskis invites pharma peers to meet at the euroPLX conference in Lisbon this week on March 20-21. Connect and discuss how you can drive business in the pharmaceutical industry with digital B2B pharma marketplaces.

If you can't make it during the event, no problem. Just drop a message to Mindaugas for an online talk with a cup of coffee after the conference.

24/02/2023

Are you looking to expand your business and increase pharma product sales in new markets? Then you need to check out the Pipelinepharma marketplace.

Our B2B platform offers a unique opportunity for manufacturers and suppliers to showcase their pharmaceuticals, medical devices and nutraceuticals to the extensive network of potential buyers.

And the best part is that you can list all your products for free for an unlimited time.

Take advantage of this opportunity to benefit from greater visibility and exposure. Find new partnerships in new markets and grow your business.

We invite you to sign up for Pipelinepharma's marketplace today to reach more customers and get quality leads:
https://bit.ly/3KvztbO

10/02/2023

Attention B2B buyers, looking for new pharma products for your portfolio 💊🧪 Pipelinepharma has just made it easier for you to know if the products available in our marketplace fit your needs. The product cards are now enriched with valuable data to help you make informed sourcing decisions.

What's new? In addition to basic CTD and GMP information, product form, country of origin, and manufacturer, you can now get data about the product:

🔸 Shelf life
🔸 Stability zones
🔸 Minimum order quantity (MOQ)
🔸 Available deal types (licencing with supply, distribution, etc.)
🔸 Whether a CPP is available
🔸 Available packs and batch sizes
🔸 Countries where a product has been registered.product

All of this information is available free of charge to our registered visitors and can be easily accessed by logging into our platform.

Check it out here: https://bit.ly/3jTOXvb

31/12/2022

Let's make 2023 a year of good deals! Find more matches, markets, and opportunities. Keep raising the bar together! ✨

02/12/2022

With B2B conferences having a comeback in 2022, both pharma buyers and sellers have more opportunities to meet in person, re-kindle old ties and learn from one another. But are in-person events the best venue for finding new deal partners?

According to Pipelinepharma CEO Mindaugas Zagorskis, more and more pharma players are using a mix of offline and online channels to discover new business opportunities:

“Talking with Pharma representatives, both online and during live events, it seems that our traditionally conservative industry is becoming more and more open to new ideas. And in the changing business landscapes, solutions that can work in the background, generating leads and potential sales, can make a massive difference.”

Read more about how trade shows and B2B marketplaces complement each other in this latest article by our CEO:
https://bit.ly/3B5l8x4

Pharma trade shows and B2B digital market places

11/11/2022

What developments will shape the biopharmaceutical industry during the next several years? has shared their predictions, which are worth a closer look.👀

Here’s what is coming up:

📉 A cliff – the biggest in recent history – is likely to shave $26 billion off the pharma sales forecast for 2028. AbbVie’s $20 billion-a-year Humira will be first to lose protection next year, with mega-blockbusters including Keytruda, Opdivo, and Eliquis to follow.

💡 Oncology will likely generate the most sales in 2028 – more than double the next largest therapy area, CNS. Its forecast growth rate of nearly 12% is also among the highest.

🍔 The fight for the share of the growing market will increase as a new generation of more effective drugs arrives and payers loosen reimbursement strings. Evaluate puts combined obesity sales in 2028 above $11 billion.

🪴The importance of -based products for the industry will continue to grow, boosted by their high price levels and multiple patents.

👉 Find the full Evaluate Pharma World Preview 2022, Outlook to 2028: Patents and Pricing report here:
https://bit.ly/3TtznSV

28/10/2022

Are you looking for new reliable deal partners? Pharma manufacturers can reach 10.000+ qualified pharma buyers worldwide and leverage high-potential B2B partnerships.

List all your products free of charge for unlimited time on the Pipelinepharma marketplace:
✅ Nutraceuticals
✅ Generics
✅ Biosimilars
✅ Medical devices

Find out more on Pipelinepharma: https://bit.ly/3gQyAh0

14/10/2022

🏭 We have added pharma descriptions to many product cards in the Pipelinepharma marketplace. That way we seek to help buyers get a clearer picture of the manufacturer’s experience and competencies.

This adds another layer of information to the already detailed product descriptions. We hope this makes it easier for buyers to find suitable products from reputable manufacturers.

⚖️ Unlike other marketplaces, we do not disclose the manufacturer’s name. We want both sides to have equal leverage when choosing deal partners.

At the same time, we provide manufacturers with the opportunity to list all their products for free by adding detailed information about each product.

Helpful search filters ensure that products are easily discoverable by interested buyers.

At , we aim to provide equal value to buyers and sellers. Only by following this principle will we be able to help both parties to conclude mutually beneficial deals.

➡️ Check the Pipelinepfarma marketplace to search for new products to enrich your portfolio:

https://bit.ly/3T0eq2A

29/09/2022

Today is World Heart Day. ❤️

Celebrated annually on 29 September, aims to increase awareness of disease (CVD) and drive international action to encourage heart-healthy living worldwide.

There are many ways you can get involved this year:
✔️ Increase awareness of CVDs by sharing information on social media
✔️ Take the World Heart Day challenge by running, walking or cycling a heart shape in your city
✔️ Illuminate a landmark in your town (it could be your office too!)

World Heart Federation shares many ways of reducing the disease and burden.

Cardiovascular disease is one of the many we try to fight by increasing access to medicines on Pipelinepharma to better prevent and treat heart failure, stroke, atrial fibrillation, and more severe conditions that often have fatal outcomes.

Pipelinepharma marketplace hosts more than 8700 generic for preventing and treating CVDs. Now on our platform, you can find dozens of aimed at improving heart health and circulation.

Take a look: https://bit.ly/3v4OPeI

08/09/2022

Being the largest B2B pharma marketplace for finished dosage products, Pipelinepharma has collected in-depth knowledge of numerous markets worldwide.🌍

So we want to share the latest industry insights with companies seeking a competitive edge — pharma buyers and suppliers.

Whether you’re preparing your go-to-market strategy or expanding your offering in a specific country, the Pipelinepharma research team is here to help.

Get an on-demand report on 70+ markets, including Germany, Denmark or Israel, that features the latest , and .

📍Got interested? Select a country, define a product, make an order and get the report in just 3 days to your inbox. Get a hold of the data that can make a huge difference today.

Want to get more information about our new Market research service? Find it here:

https://bit.ly/3qnWUIR

18/08/2022

What are the benefits of joining as a health products manufacturer? Where else would you get the opportunity to be discovered by 10K+ prospecting B2B buyers?

We have got all geographies covered with these countries in the lead by the number of qualified distributors in:
✅ Europe: Germany - 608, Italy - 608, UK - 303
✅ North America: USA - 572, Brazil - 285, Canada - 242
✅ Asia: China - 726, Vietnam - 436, Thailand - 436
✅ CIS, MENA, Africa: Kazakhstan - 269, Turkey - 243, Egypt
241
and many more.

And our buyers are looking for more than just . In early autumn, we planning to add and to our list of categories.

If your company produces any of the above, we welcome you to register today. And to make it easier for you, we can add all of your products to the platform for you. Simply share the list of products via support@pipelinepharma.com, and our team will list them for you for free.

Learn more: https://www.pipelinepharma.com/seller/?utm_campaign=SM-buyers-in-europe&utm_medium=social&utm_source=Facebook

05/08/2022

A fascinating read about Cost Plus Drugs, Mark Cuban’s venture that has the potential to democratize to pharmaceuticals. The Dallas-based billionaire is set to cut out the middle man, slash markups, and offer patients prescription drugs at affordable prices.

And while there is already a wide selection of on the platform, the company is yet to find a way of breaking into brand-name drugs. Although brand-name drugs make up a smaller share of prescriptions than generics, they accounted for nearly 80% of prescription drug expenditures in 2018, according to IQVIA.

Cost Plus Drugs succeeds in cutting generic costs by eliminating pharmacy benefit managers from the equation and negotiating wholesale prices from manufacturers. The platform can boost the already record-high pe*******on rate of generics in the US. And if the platform ever expands to other countries, where the pe*******on rate is relatively low, a ripple effect might be expected.

shares the same goal of increasing access to affordable medication worldwide. This is why we facilitate deals between buyers and 1800+ manufacturers of generic drugs. Following the latest trends in healthcare, we’re also adding new categories that will benefit all parties (including patients, of course) in the nearest future.

👉 Find the whole publication about Cost Plus Drugs here:

Mark Cuban's Cost Plus Drugs is delivering steep discounts on hundreds of prescription drugs, but it may not have the brand-name drugs you need yet. Here's why.

28/07/2022

🔍 Our search function has just got even better!

Pipelinepharma users will be happy to learn that we have integrated an Anatomical Therapeutic Chemical ( ) filter. Replacing the Therapy areas filter, this new functionality will help buyers search for products using the widely used WHO classification system.

Just a reminder that you can also filter search results by Form, Country of origin, Dossier status, Dossier type and GMP approvals.

👉 Find new products in 5 minutes in the marketplace:
https://bit.ly/3PYtYSh

22/07/2022

Some of you might have noticed a recent decrease in the number of pharma products available on the platform – from 86 000+ to 84 000+. At , we’re both serious and transparent about our numbers. So let us explain.

With the war against 🇺🇦 Ukraine, we can no longer support commercial relations with Russia and Belarus. Taxes paid in those countries are fuelling a brutal war in Europe, and we have joined a growing number of businesses that have purposefully decided to cut ties. We stand with Ukraine and its people.

manufactured in Russia and Belarus never formed a significant part of our platform’s listings, most of which have available counterparts produced in other countries. And if you find something missing, just let us know, we’re constantly expanding our selection, and we’ll soon return with some exciting news!

Find many popular and niche pharmaceuticals on the largest B2B pharma in Europe:
https://bit.ly/3B42yGD

06/07/2022

Ready to find your perfect pharma partner? All successful deals start with a request for quotation - and we've shared our top tips.

is here to connect you with the right manufacturer. It’s our goal to make your pharmaceutical sourcing as smooth as possible, so you can easily submit an RFQ on our B2B platform.

In a new article, Ruta Zagorskyte, our Business Development Manager, shares key tips for putting together a solid RFQ that will land you the best deal for your business:
👇
https://bit.ly/3a97zml

Sharing tips on what information is needed to submit a request for proposal (RFQ) and get a relevant proposal from a pharma manufacturer.

30/06/2022

Generic drugs account for nearly 30% of all pharmaceutical sales in Europe. In countries like Italy, Austria and Poland, this share is much higher.

The latest data from EFPIA - European Federation of Pharmaceutical Industries and Associations - shows that make a major contribution to the European drug supply. And due to growing healthcare costs and market liberalisation efforts, generics pe*******on in Europe is only set to increase.

If you are looking for your way into Europe’s generics market, Pipelinepharma has you covered. Our leading European pharmaceutical marketplace features 600+ EU GMP manufacturers listing over 84,000 finished dosage formulation products.

Find more key figures on Europe’s industry from EFPIA here: https://bit.ly/3I0FQAJ

Sign up to Pipelinepharma today: https://bit.ly/3bECsix